OHDSI Home | Forums | Wiki | Github

Weekly OHDSI Digest - 27Jan2020

(Maura Beaton) #1


OMOP CDM Oncology WG - Genomic Subgroup Meeting - Tuesday at 9am ET
URL: https://us04web.zoom.us/j/412862164?pwd=NmpEWTdTQlB4N3VxT0tQRXdDWlg0dz09

OHDSI Community Call - Tuesday at 12pm ET
Webex: https://meetings.webex.com/collabs/#/meetings/detail?uuid=M59X2V1U61WC9ASID2Z5N3UT95-D1JL&rnd=96139.930901412523321531221112212141232121131213113112112121536

Oncology WG - Development Subgroup Meeting - Wednesday at 10am ET
URL: https://www.ohdsi.org/web/wiki/doku.php?id=documentation:oncology:development_schedule

OMOP CDM Oncology WG - CDM/Vocabulary Subgroup Meeting - Thursday at 10am ET
URL: https://us04web.zoom.us/j/755053125?pwd=V0dOZVVnY3RMRWgxMVVGTDdVbnA1UT09

You can find a full list of upcoming OHDSI meetings here: https://docs.google.com/document/d/1X0oa9R-V8cwpF1WQZDJOqcXZguPKRiCZ6XrQ2zXMiuQ/edit


Favorite 2019 OHDSI Papers - We want to create a thread of the community’s favorite or most inspiring OHDSI papers from the past 12 months.Was there a paper that used OHDSI tools and standards particularly inspiring to you? Please share them here: Favorite OHDSI Papers Of 2019

Two OHDSI studies published in Lancet! Another OHDSI study has been published in Lancet! The EHDEN team’s Rheumatology paper is available here: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(19)30075-X/fulltext
If you haven’t yet checked out the LEGEND hypertension study in the Lancet, you can check it out here:
For more info on the study, check out our press release:

2019 OHDSI Symposium - Tutorial Videos Videos from the 2019 OHDSI tutorials are officially online! You can access tutorial videos and materials here:

I know it sounds weird, but how bad, how hard can dying be?


Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults.

Opioid prescriptions in patients with osteoarthritis: a population-based cohort study.

Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease.